Indee Labs


Developer of a non-viral intracellular delivery system designed to deliver nucleic acids, proteins and gene editing complexes to the patient and donor T cells with minimal perturbation. The company’s system is easy-to-integrate with standard reagents, cells are processed at 1.5M per second and yield the maximum amount of recovered, viable and modified cells, enabling researchers to have efficient development and scalable Manufacturing of gene-modified cell therapies.

626 Bancroft Way Suite A
Berkeley, CA 94710